Form 4: Inhibrx Biosciences Director Jon Faiz Kayyem Reports Gift of Shares

Director Jon Faiz Kayyem of Inhibrx Biosciences reported a gift of 52,000 common shares from a family trust to his adult children.

Summary

• Jon Faiz Kayyem, a director at Inhibrx Biosciences, filed a Form 4 indicating a change in beneficial ownership of company stock.
• The transaction involved a gift of 52,000 common shares from The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to Mr. Kayyem's adult children.
• Mr. Kayyem disclaims beneficial ownership of these gifted shares.
• Following the transaction, Mr. Kayyem's indirect ownership includes 1,009,360 shares held by the family trust, and 69,843 shares each held in custodial accounts for two minor children.
• Mr. Kayyem disclaims beneficial ownership of the shares held in the family trust and custodial accounts, except for any indirect pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing and does not contain any information that would indicate a positive or negative sentiment.

Industry Context

This is a routine filing related to changes in beneficial ownership by a company director, which is a common occurrence in publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders, such as directors, to report changes in their ownership of company stock.
• The reporting requirements are mandated by the SEC to ensure transparency and prevent insider trading.
• The details provided in this filing are consistent with what is expected in similar filings from other publicly traded companies.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a transfer of shares from a family trust to family members and does not change the total number of outstanding shares.

Key Dates

Keywords

Form 4, beneficial ownership, Inhibrx Biosciences, Jon Faiz Kayyem, stock gift, director, share transfer